These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37153146)

  • 41. Risk factors and outcomes for carbapenem-resistant Klebsiella pneumoniae bacteremia in onco-hematological patients.
    Liu J; Wang H; Huang Z; Tao X; Li J; Hu Y; Dou Q; Zou M
    J Infect Dev Ctries; 2019 May; 13(5):357-364. PubMed ID: 32053504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
    Chen J; Ma H; Huang X; Cui Y; Peng W; Zhu F; Ma S; Rao M; Zhang P; Yang H; Su L; Niu R; Pan P
    Antimicrob Resist Infect Control; 2022 Dec; 11(1):161. PubMed ID: 36536423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region.
    Menekşe Ş; Çağ Y; Işık ME; Şahin S; Hacıseyitoğlu D; Can F; Ergonul O
    Int J Infect Dis; 2019 Sep; 86():208-211. PubMed ID: 31402295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Initial empirical antibiotics of non-carbapenems for ESBL-producing E. coli and K. pneumoniae bacteremia in children: a retrospective medical record review.
    Park S; So H; Kim MN; Lee J
    BMC Infect Dis; 2022 Nov; 22(1):866. PubMed ID: 36404302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome.
    Tumbarello M; Spanu T; Sanguinetti M; Citton R; Montuori E; Leone F; Fadda G; Cauda R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):498-504. PubMed ID: 16436702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
    Kang CI; Kim SH; Kim DM; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
    Infect Control Hosp Epidemiol; 2004 Oct; 25(10):860-7. PubMed ID: 15518030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiology of carbapenem-resistant
    Wang Y; Lei H; Zhang Y; Yang Q; Wang Y; Wang J; Xu C; Yu J; Zhou L; Kang X; Cui L
    Antimicrob Resist Infect Control; 2018; 7():66. PubMed ID: 29942492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors and outcomes for bloodstream infections with extended-spectrum beta -lactamase-producing Klebsiella pneumoniae ; Findings of the nosocomial surveillance system in Hungary.
    Szilágyi E; Füzi M; Böröcz K; Kurcz A; Tóth A; Nagy K
    Acta Microbiol Immunol Hung; 2009 Sep; 56(3):251-62. PubMed ID: 19789140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-β-Lactamase-1.
    Dong F; Zhang Y; Yao K; Lu J; Guo L; Lyu S; Yang Y; Wang Y; Zheng H; Song W; Liu G
    Microb Drug Resist; 2018 Mar; 24(2):154-160. PubMed ID: 28594635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology of
    Tian L; Tan R; Chen Y; Sun J; Liu J; Qu H; Wang X
    Antimicrob Resist Infect Control; 2016; 5():48. PubMed ID: 27891222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
    Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
    Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
    Ny P; Nieberg P; Wong-Beringer A
    Am J Infect Control; 2015 Oct; 43(10):1076-80. PubMed ID: 26190386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.
    Viale P; Giannella M; Lewis R; Trecarichi EM; Petrosillo N; Tumbarello M
    Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1053-63. PubMed ID: 24073806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection.
    Chen J; Li J; Huang F; Fang J; Cao Y; Zhang K; Zhou H; Cai J; Cui W; Chen C; Zhang G
    BMC Pulm Med; 2023 Mar; 23(1):102. PubMed ID: 36978069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
    Kim SH; Kwon JC; Choi SM; Lee DG; Park SH; Choi JH; Yoo JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Ann Hematol; 2013 Apr; 92(4):533-41. PubMed ID: 23161391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study.
    Shilo S; Assous MV; Lachish T; Kopuit P; Bdolah-Abram T; Yinnon AM; Wiener-Well Y
    Infection; 2013 Apr; 41(2):503-9. PubMed ID: 23271210
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors for and mortality of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections.
    Superti SV; Augusti G; Zavascki AP
    Rev Inst Med Trop Sao Paulo; 2009; 51(4):211-6. PubMed ID: 19739001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.
    Peña C; Pujol M; Ardanuy C; Ricart A; Pallares R; Liñares J; Ariza J; Gudiol F
    Antimicrob Agents Chemother; 1998 Jan; 42(1):53-8. PubMed ID: 9449260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.